A1M Pharma AB (A1M)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:A1M Pharma AB (A1M) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010867
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
A1M Pharma AB (A1M Pharma) develops and commercializes drug candidate for the diagnosis and treatment of pre-eclampsia (pandemic poisoning) and acute renal injury. The company offers ROSgard based on A1M (alpha-1-microglobulin), an endogenous protein with properties that captures and eliminates toxic substances from the cells metabolism. Its A1M helps to prevent and ameliorate some of the damage caused by oxidative stress and inflammation. A1M Pharma develops novel diagnostic test for preeclampsia based on the biomarker fetal hemoglobin. The company also develops treatments for kidney damage. It provides constitute therapeutic or diagnostic tools for various conditions and illnesses in animals and humans. A1M Pharma is headquartered in Lund, Sweden.

A1M Pharma AB (A1M) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
A1M Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
A1M Pharma AB, Medical Devices Deals, 2011 to YTD 2017 9
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
A1M Pharma AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
A1M Pharma Partnered with Clinical Trial Consultants 11
A1M Pharma Enters into Agreement with Research Toxicology Centre 12
A1M Pharma Enters into Research Agreement with CSL Behring 13
A1M Pharma Enters into Rresearch Agreement with Fred Hutchinson Cancer Research Centre 14
A1M Pharma Expands Agreement with European Pharmaceutical Company 15
A1M Pharma Enters into Partnership with Truly Translational 16
NeuroVive Pharmal And A1M Pharma Enter Into Research Agreement 17
Equity Offering 18
A1M Pharma Plans to Raise USD13.82 Million in Public Offering of Shares 18
A1M Pharma Raises USD5 Million in Rights Offering of Shares 19
A1M Pharma Raises USD3.7 Million in Rights Offering of Shares 20
A1M Pharma Raises USD3.61 Million in Rights Offering of Shares 21
A1M Pharma AB – Key Competitors 22
A1M Pharma AB – Key Employees 23
A1M Pharma AB – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Product News 25
09/13/2016: A1M Pharma selects kidney protection in connection with cancer treatment as their first indication within acute kidney injury 25
02/10/2017: A1M Pharma has successfully conducted large scale manufacturing of the active substance in ROSGard and initiates GLP toxicology studies 26
Product Approvals 27
Sep 09, 2016: A1M Pharma applies for trademark protection for ROSGard as the name of the companys candidate drug RMC-035 27
Clinical Trials 28
Jun 12, 2017: A1M Pharma announces progress in the preclinical development of ROSGard 28
Mar 29, 2017: A1M Pharma: ROSGard shows strong protective effect against renal damage in connection with radiation therapy in a preclinical long-term study 29
Dec 09, 2016: ROSGard shows renal protective effect during radiation therapy 30
Nov 29, 2016: A1M Pharma has successfully conducted preclinical toxicology/safety studies within preeclampsia 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
A1M Pharma AB, Pharmaceuticals & Healthcare, Key Facts 2
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
A1M Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
A1M Pharma AB, Deals By Therapy Area, 2011 to YTD 2017 8
A1M Pharma AB, Medical Devices Deals, 2011 to YTD 2017 9
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
A1M Pharma Partnered with Clinical Trial Consultants 11
A1M Pharma Enters into Agreement with Research Toxicology Centre 12
A1M Pharma Enters into Research Agreement with CSL Behring 13
A1M Pharma Enters into Rresearch Agreement with Fred Hutchinson Cancer Research Centre 14
A1M Pharma Expands Agreement with European Pharmaceutical Company 15
A1M Pharma Enters into Partnership with Truly Translational 16
NeuroVive Pharmal And A1M Pharma Enter Into Research Agreement 17
A1M Pharma Plans to Raise USD13.82 Million in Public Offering of Shares 18
A1M Pharma Raises USD5 Million in Rights Offering of Shares 19
A1M Pharma Raises USD3.7 Million in Rights Offering of Shares 20
A1M Pharma Raises USD3.61 Million in Rights Offering of Shares 21
A1M Pharma AB, Key Competitors 22
A1M Pharma AB, Key Employees 23
A1M Pharma AB, Subsidiaries 24

★海外企業調査レポート[A1M Pharma AB (A1M)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Astronics AeroSat Corporation:企業の戦略・SWOT・財務情報
    Astronics AeroSat Corporation - Strategy, SWOT and Corporate Finance Report Summary Astronics AeroSat Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Central Rand Gold Ltd:企業の戦略・SWOT・財務情報
    Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dais Analytic Corps (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Analytic Corps (Dais) is an alternative energy company that provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV an …
  • Industrial Alliance Insurance and Financial Services Inc.:企業のM&A・事業提携・投資動向
    Industrial Alliance Insurance and Financial Services Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Industrial Alliance Insurance and Financial Services Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includ …
  • YTL Power International Berhad:発電所・企業SWOT分析
    YTL Power International Berhad – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Innocoll AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product Xaracoll, a bupivacaine HC …
  • Botswana Power Corporation:企業の戦略的SWOT分析
    Botswana Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Electrica SA (EL):企業の財務・戦略的SWOT分析
    Electrica SA (EL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bancolombia SA (BCOLOMBIA):企業の財務・戦略的SWOT分析
    Bancolombia SA (BCOLOMBIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Gulf Keystone Petroleum Ltd (GKP):企業の財務・戦略的SWOT分析
    Summary Gulf Keystone Petroleum Ltd (Gulf Keystone) is an oil and gas company that offers operation and production of oil and natural gas reserves. The company operates working interests in the Republic of Algeria and the Kurdistan Region of Northern Iraq. Its Kurdistan Region of Iraq operates produ …
  • Gene Biotherapeutics Inc (CRXM):企業の財務・戦略的SWOT分析
    Gene Biotherapeutics Inc (CRXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • GUD Holdings Limited (GUD):企業の財務・戦略的SWOT分析
    GUD Holdings Limited (GUD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lotte Shopping Co., Ltd.:企業の戦略・SWOT・財務情報
    Lotte Shopping Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lotte Shopping Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sunnova Energy Corporation:電力:M&Aディール及び事業提携情報
    Summary Sunnova Energy Corporation (Sunnova Energy) is engaged in providing solar power services to homeowners. The company is involved in installing and generating power. It offers solar service agreements such as EZ Pay PPA, PPA, EZ own plan, and solar lease plan. In addition, the company offers s …
  • Impax Laboratories Inc (IPXL)-製薬・医療分野:企業M&A・提携分析
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • National Health Research Institutes:製薬・医療:M&Aディール及び事業提携情報
    Summary National Health Research Institutes (NHRI) is a non-profit foundation that performs medical research programs. The foundation investigates various aspects of basic biomedical sciences and diseases including aging, cancer, infectious diseases, mental disorders and occupational diseases. It co …
  • Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monova …
  • AstraZeneca AB-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca AB (AstraZeneca), a subsidiary of AstraZeneca Plc is a healthcare products provider that research and development of medicinal products. The company offers research and produces drug products in heart and cardiovascular, infection, cancer, metabolic diseases, respiratory, stomach …
  • Takenaka Corporation:企業の戦略・SWOT・財務情報
    Takenaka Corporation - Strategy, SWOT and Corporate Finance Report Summary Takenaka Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Gexa Energy LP:企業の戦略的SWOT分析
    Gexa Energy LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆